Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 349 of 349 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/03
End: -
Due: -
Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 01/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/97
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 02/04/18
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 06/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/01/25
End: 09/18/31
Due: 09/18/32
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 03/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/11/22
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 05/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 09/24/17
Due: 09/24/18
Phase: N/A
Priority: Normal
Start: 07/31/96
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/02
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/10/17
End: 12/31/27
Due: 12/31/28